Skip to Content


In the US, Reminyl (galantamine systemic) is a member of the drug class cholinesterase inhibitors and is used to treat Alzheimer's Disease.

US matches:

UK matches:

Ingredient matches for Reminyl


Galantamine is reported as an ingredient of Reminyl in the following countries:

  • Egypt
  • Italy
  • Lebanon
  • Turkey

Galantamine hydrobromide (a derivative of Galantamine) is reported as an ingredient of Reminyl in the following countries:

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • China
  • Colombia
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Iceland
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Lithuania
  • Malta
  • Mexico
  • Myanmar
  • Netherlands
  • New Zealand
  • Norway
  • Oman
  • Philippines
  • Portugal
  • Romania
  • Serbia
  • Singapore
  • South Africa
  • Taiwan
  • Thailand
  • United Kingdom
  • Vietnam

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.